Synthesis, characterization, and anticonvulsant activity of enaminones. Part 5: Investigations on 3-carboalkoxy-2-methyl-2,3-dihydro-1H-phenothiazin-4[10H]-one derivatives

Bioorganic and Medicinal Chemistry

Volumn 6, Issue 12, 1998, Pages 2289-2299

  Laws, Mia L ^a   Roberts, Ralph R ^b   Nicholson, Jesse M ^c   Butcher, Raymond ^c   Stables, James P ^d   Goodwin, Angela M ^c   Smith, Carlynn A ^c   Scott, K R ^c  

^a DUPONT COMPANY   (United States)

^b 3M COMPANY   (United States)

^c HOWARD UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Anticonvulsants; NMR; X ray crystal structures

Indexed keywords

3 CARBO TERT BUTOXY 2 METHYL 2,3 DIHYDRO 1H PHENOTHIAZIN 4(10) ONE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; REACTION ANALYSIS; SEIZURE; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

EID: 0032423284     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(98)80009-6     Document Type: Article

References (31)

1. Edafiogho, I. O.; Hinko, C. N.; Chang, H.; Moore, J. A.; Mulzac, D.; Nicholson, J. M.; Scott, K. R. J. Med. Chem. 1992, 35, 2798.
2. Scott, K. R.; Edafiogho, I. O.; Richardson, E. L.; Farrar, V. A.; Moore, J. A.; Tietz, E. I.; Hinko, C. N.; Chang, H.; El-Assadi, A.; Nicholson, J. M. J. Med. Chem. 1993, 36, 1947.
3. Mulzac, D.; Scott, K. R. Epilepsia 1993, 33, 1141.
4. Edafiogho, I. O.; Alexander, M. S.; Moore, J. A.; Farrar, V. A.; Scott, K. R. Curr. Med. Chem. 1994, 1, 161.
5. Scott, K. R.; Rankin, G. O.; Stables, J. P.; Alexander, M. S.; Edafiogho, I. O.; Farrar, V. A.; Kolen K. R.; Moore, J. A.; Sims, L. D.; Tonnu, A. D. J. Med. Chem. 1995, 38, 4033.
6. Roberts, R. R.; Edafiogho, I. O.; Scott, K. R. US Patent No. 5,580,894, 1996.
7. Gupta, R. R. Phenothiazines and 1,4-benzothiazines. Chemical and Biomedical Aspects; Elsevier: Amsterdam, 1988.
8. Benz, G.; Fengler, G.; Meyer, H.; Niemers, E.; Fiedler, V.; Mardin, M.; Mayer, D.; Perzborn, E.; Seuter, F. Chem. Abstr. 1986, 105, 60620y; Ger. Offen. DE 3,426,564.
9. Niemers, E.; Gruetzmann, R.; Mardin, M.; Busse, W. D.; Meyer, H. Chem. Abstr. 1984, 100, 185787k, Ger. Offen. DE 3,229,122.
10. Gupta, R. R.; Saraswat, V.; Gupta, V.; Rajoria, C. M.; Gupta, A.; Jain, M. S. J. Heterocyclic Chem. 1993, 30, 803.
11. Chorvat, R. J.; Desai, B. N.; Radak, S. E.; Bloss, J.; Hirsch, J.; Tenen, S. J. Med. Chem. 1983, 26, 845.
12. Roberts, R. R.; Landor, S. R. Tetrahedron Lett. 1993, 34, 5681.
13. Miyano, S.; Abe, N.; Sumoto, K. J. Chem. Soc. Chem. Comm. 1975, 760.
14. Mital, R.; Jain, S. K. J. Chem. Soc. (C) 1969, 2148.
15. Alaimo, R. J. J. Heterocydic Chem. 1971, 8, 309.
16. Gupta R. R.; Ojha, K. G.; Kumar, M. J. J. Heterocyclic Chem. 1980, 17, 803.
17. Friary, R. J.; Gilligan, J. M.; Szajewski, R. P.; Falci, K. J.; Franck, R. W. J. Org. Chem. 1973, 38, 3487.
18. Miyano, S.; Abe, N.; Sumoto, K. Teramoto, K. J. Chem. Soc. Perkin. 1 1976, 1146.
19. (a) Anticonvulsant Screening Project, Antiepileptic Drug Development Program, National Institutes of Health, DHEW Publ (NIH)(U.S.) 1978, NIH 78-1093.
20. (b) Porter, R. J.; Cereghino, J. J.; Gladding, G. D.; Hessie, B. J.; Kupferberg, H. J.; Scoville, B.; White, B. G. Cleveland Clin. Q. 1984, 51, 293.
21. (c) Krall, R. L.; Penry, J. K.; White, B. G.; Kupferberg, H. J.; Swinyard, E. A. Epilepsia 1978, 19, 400.
22. Racine, R. J. Electroencephalogr. Clin. Neurophysiol. 1972, 32, 281.
23. Piredda, S. G.; Woodhead, J. H.; Swinyard, E. A. J. Pharmacol. Exp. Ther. 1985, 232, 741.
24. Alexander, M. S.; Stables, J. P.; Ciechanowicz-Rutkowska, M.; Hursthouse, M. B.; Hibbs, D. E.; Edafiogho I. O.; Farrar, V. A.; Moore, J. A.; Scott, K. R. Eur. J. Med. Chem. 1996, 31, 787.
25. MacLogP Program; version 2.0, BioByte Corp. Claremont, CA 91711.
26. Newmeyer, J. L.; Booth, R. G. In Principles of Medicinal Chemistry; Foye, W. O.; Lemke, T. L.; Williams, D. A., Eds.; Williams and Wilkins: Baltimore, 1995; Ch. 12.
27. Taft, R. W. In Steric Effects in Organic Chemistry; Newman, M. S., Ed.; J. Wiley and Sons: New York, 1956; pp 556-675.
28. (a) Craig, P. N. J. Med. Chem. 1971, 14, 680.
29. (b) Craig, P. N. J. Med. Chem. 1972, 15, 144.
30. Sheldrick, G. M. ShelXLTLPC and ShelXTL. Program for crystal structure determination, 1996. Cambridge University, England.
31. Swinyard, E. A.; Woodhead, J. H.; White, H. W.; Franklin, M. R. In Antiepileptic Drugs, 3rd ed.; Levy, R. H.; Dreifuss, F. E.; Mattson, R. H.; Meldrum, B. S.; Penry, J. K., Eds.; Raven: New York, 1989; pp 85-102.